Clinical value of fulvestrant in breast cancer.
Gradishar
William J
WJ
Robert H. Lurie Comprehensive Cancer Center and NorthWestern University Feinberg School of Medicine, 676 North St. Clair Street, Chicago, IL 60611, USA. w-gradishar@northwestern.edu
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D002986:Clinical Trials as Topic; D017277:Drug Approval; D004958:Estradiol / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D004965:Estrogen Antagonists / Q000627:therapeutic use*; D005260:Female; D000077267:Fulvestrant; D006801:Humans; D020845:Selective Estrogen Receptor Modulators / Q000627:therapeutic use*; D014481:United States
D018931:Antineoplastic Agents, Hormonal; D004965:Estrogen Antagonists; D020845:Selective Estrogen Receptor Modulators; D000077267:Fulvestrant; D004958:Estradiol